The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zhulimova N.L.

Ural'skiĭ nauchno-issledovatel'skiĭ institut dermatovenerologii i immunopatologii Ministerstva zdravookhraneniia i sotsial'nogo razvitiia Rossiĭskoĭ Federatsii

Zil'berberg N.V.

State federal facility "Ural Research Institute of Dermatovenerology and Immunopathology", Ekaterinburg

Levchik N.K.

FGBU "Ural'skiĭ nauchno-issledovatel'skiĭ institut dermatovenerologii i immunopatologii", Ekaterinburg

Clinical observation of Behçet's disease in a 33-year-old woman

Authors:

Zhulimova N.L., Zil'berberg N.V., Levchik N.K.

More about the authors

Journal: Therapeutic Archive. 2014;86(12): 43‑46

Read: 4470 times


To cite this article:

Zhulimova NL, Zil'berberg NV, Levchik NK. Clinical observation of Behçet's disease in a 33-year-old woman. Therapeutic Archive. 2014;86(12):43‑46.

Recommended articles:
Infi­ltrative-ulcerative lesion of the larynx in Behcet’s disease. Russian Bulletin of Otorhinolaryngology. 2025;(4):112-114

References:

  1. Hatemi G., Yazici Y., Yazici H.  Behcet's syndrome. Rheum Dis Slin North Am. 2013 May; 39 (2): 245-61. doi: 10.1016/j.rdc.2013.02.010/ Epub 2013 Mar 14.
  2. Pohl D., Benseler S.  Systemic inflammatory and autoimmune disorders. Handb Clin Neurol 2013; 112: 1243-1252.
  3. Al-Araji A., Kidd D.P.  Neuro-Behcet's diseases: epidemiology, clinical characteristics, and management. Lancet Neurol 2009; 8 (2): 192-204.
  4. Измайлова Ф.И., Алекберова З.С.  Bolezn' Bekhcheta: demograficheskie i geneticheskie aspekty (Obzor literatury). Sovremennaya revmatologiya. 2014; 1: 53-58.
  5. Алекберова З.С.  Bolezn' Bekhcheta. Moskva: RAMN i GU RAMN; 2007.
  6. Алекберова З.С., Измаилова Ф.И., Кудаев М.Т.  Bolezn' Bekhcheta: kliniko-demograficheskie assotsiatsii. Terapevticheskii arkhiv 2013; 85 (5): 48-52.
  7. Yazici Y., Yurdakul S., Yazici H.  Behcet's syndrome. Curr Rheumatol rep. 2010 Dec; 12 (6): 429-35. doi: 10.1007/11926-010-0132-z.
  8. Ohno S., Aoki K., Sugiura S. et al.  Immunohematological studies on Behcet's disease. Histocompatibility (HL-A) antigens and I blood group system (author's transl.). Nicon Ganka Gakkai Zasshi. 1973; 77 (9): 1452-1458.
  9. Tappuni A.R., Tbakhi A., Sharguite K.E. et al.  A comparative study of the genetics of Behcetçs disease in Iraq: international collaboration to transfer clinical and laboratory skills to Baghdad medical school and hospitals. Med Confl Survive 2013; 29 (1): 57-68.
  10. Guarene M., Capittini C., De Silvestri A. et al.  Targeting the immunogenetic diseases with the appropriate HLA molecular typing: critical appraisal on 2666 patients typed in one single centre. Biomed Res Int. 2013; 2013:904247. doi:10.1155/2013/904247. Epub 2013 Jan 21.
  11. Hughes T., Coit P., Adler A. et al.  Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat Genet 2013; 45 (3): 319-324.
  12. Kalayciyan A., Zouboulis C.C.  An update on Behcet's disease. J Eur Acad Dermatol Venereol 2007; 21 (1): 1-10.
  13. Yanagihori H., Oyama N., Nakamura K. et al.  Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: An involvement of Th1 immunoreactivity against Streptococcus sanguinis antigen. J Invest Dermatol 2006; 126 (7): 1534-1540.
  14. Cho S., Zheng Z., Cho S. et al.  Both the sera of patients with Behçet's disease and Streptococcus sanguis stimulate membrane expression of hnRNP A2/B1 in endothelial cells. Scand J Rheumatol 2013; 42 (3): 241-246.
  15. Miyake S.  Innate immunity in neuroimmunlogical disorders. Nihon Rinsho 2013; 71 (5): 778-782.
  16. Hamzaoui K., Kahon A., Hanza M., Ayed K.  Supressive T cell function of Epstein-Barr virus induced B cell activation in active Behçet's disease. Clin Exp Rheumatol 1991; 9 (2): 131-135.
  17. Lee S.H., Kim S.D., Kim S.H. et al.  EBV-associated haemophagocytic syndrome in a patient with Behçet's disease. Scand J Rheumatol 2005; 34 (4): 320-323.
  18. Kuhara T., Watanabe D., Ishida N. et al.  Quantitative analysis of shedding of Epstein-Barr virus in saliva from patients with connective tissue disease: a pilot study. Int J Dermatol 2013; 52 (7): 887-890.
  19. Жулимова Н.Л., Бочкарев Ю.М., Чигвинцева Е.А., Сурганова В.И.  Ostraya yazva vul'vy. Klin dermatol i venerol 2006; 1: 33-35.
  20. Hatemi G., Yazuci H.  Behçet's syndrome and micro-organisms. Best Pract Res Clin Rheumatol. 2011; 25 (3): 389-406.
  21. Вольф К., Голдсмит Л.А., Кац С.И. и др.  Dermatologiya Fitspatrika v klinicheskoi praktike: v 3 t.: (per. s angl.) M.: Izd-vo Panfilova; 2012.
  22. Hatemi G., Silman A., Bang D. et al.  EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008; 67 (12): 1656-1662.
  23. The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. JEADV 2014; 28: 338-347.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.